where to inject a glp 1 Injection Site Matters: Optimizing GLP-1 Effectiveness #stitch @amy this is a

JP Morgan Targets Weight Loss Drugs With $500M Fund The current duopoly in the GLP-1 game figures to be short-lived as more investors enter the space, experts say JP Morgan Private Capital, a venture capital and growth equity investment team under JP Morgan Asset Management, has raised over $500 million for a life sciences fund targeting private biotech companies and the booming weight-loss drug space

10.3389/fimmu.2021.656797 143 SabbadiniR

J., Morris, S

Specifically, SGLT2 inhibitor use was associated with a lower risk of PE compared with DPP-4 inhibitors (HR 0.44, 95% CI 0.300.64), while a more modest reduction was observed for DVT (HR 0.82, 95% CI 0.680.99) [24]

Thyroid C-cell tumours : Animal studies (rodents) have identified a signal for thyroid C-cell tumours with GLP-1 receptor agonists